Cefolist T 250mg/31.25mg Injection
Marketer
Rech Elist Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefolist T 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; complete the prescribed regimen, even with symptom improvement, to maximize efficacy. Premature cessation may compromise treatment. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician prior to commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to optimal recovery. Your physician may order laboratory and diagnostic tests to monitor therapeutic response.
Primary Ingredients of Cefolist T 250mg/31.25mg Injection
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Cefolist T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefolist T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefolist T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefolist T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefolist T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefolist T 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Cefolist T 250mg/31.25mg Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefolist T 250mg/31.25mg injections are typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Cefolist T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Cefolist T (250mg/31.25mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefolist T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Cefolist T 250mg/31.25mg requires careful administration for individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Cefolist T 250mg/31.25mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefolist T 250mg/31.25mg Injection :
Should you inadvertently skip a dose of Cefolist T 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Cefolist T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently